Editing PHKG Business Opportunities (section)

=== Competitive Landscape ===

'''Major competitors (wiki previously omitted):'''

* '''Epic's own AI chart summarisation (GPT-4 powered):''' Deployed nationally across US health systems including NYU Langone, scaled in 2024-25. This is the product Stamen would compete with directly. Source: NYU Langone study on automation bias.<ref>NYU Langone Epic GPT-4 summarisation study (2025) — automation bias in clinical AI chart review.</ref>

* '''Helseplattformen (Norwegian Epic deployment):''' Mid-Norway region. Adds complexity — potentially gives Epic a foothold for chart-summarisation features in Norway. Stamen would be competing against Epic's own AI features in Helseplattformen regions.

* '''Abridge, Nabla, Suki, DeepScribe:''' Primarily ambient documentation but expanding into chart review/summarisation. Well-funded.

* '''Microsoft/Nuance DAX Copilot:''' Same direction — ambient documentation expanding to chart summarisation.

* '''Tandem Health''' (Sweden/Norway) — AI clinical documentation with EHR access already negotiated. Nordic competitor with market presence.

* '''Cogstack''' (UK) — NHS clinical NLP, open source, extracts from unstructured notes. Research tool, not commercial product.

'''The framing "no existing GP tool does AI summarisation of full history" was true in 2023. By 2026 it is actively contested.'''